Etomidate and Hyperthyroid - a phase IV clinical study of FDA data

Summary:

Hyperthyroid is reported as a side effect among people who take Etomidate (etomidate), especially for people who are female, 60+ old, also take Lidocaine, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Hyperthyroid when taking Etomidate. It is created by eHealthMe based on reports of 2,491 people who have side effects when taking Etomidate from the FDA, and is updated regularly.

What is Etomidate?

Etomidate has active ingredients of etomidate. eHealthMe is studying from 2,496 Etomidate users. Check the latest studies of Etomidate.

What is Hyperthyroid?

Hyperthyroid is found to be associated with 1,143 drugs and 1,401 conditions by eHealthMe. Check the latest studies of Hyperthyroid.

On Nov, 01, 2025

2,491 people reported to have side effects when taking Etomidate.
Among them, 12 people (0.48%) have Hyperthyroid.

Among these 12 people:

What is the gender of people who have Hyperthyroid when taking Etomidate? *

female: 100 %
male: 0.0 %

What is the age of people who have Hyperthyroid when taking Etomidate? *

What are other drugs people take besides Etomidate? *

What are other side effects people have besides Hyperthyroid? *

Endocrine Ophthalmopathy (increased water content of retroocular orbital tissues; associated with thyroid disease, usually hyperthyroidism): 8 people, 66.67%
Diplopia (double vision): 8 people, 66.67%
Periodontal Disease (disease that attacks the gum and bone and around the teeth): 8 people, 66.67%
Palatal Oedema (excessive accumulation of watery fluid in the roof of the mouth): 8 people, 66.67%
Palatal Disorder: 8 people, 66.67%
Osteoporosis (bones weak and more likely to break): 8 people, 66.67%
Osteopenia (a condition where bone mineral density is lower than normal): 8 people, 66.67%
Osteonecrosis Of Jaw (death of bone of jaw): 8 people, 66.67%
Osteomyelitis (infection of bone): 8 people, 66.67%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 8 people, 66.67%

What are the existing conditions these people have? *

Urticaria Pigmentosa (skin disease that produces patches of darker skin (lesions) and very bad itching): 8 people, 66.67%
Multiple Myeloma (cancer of the plasma cells): 8 people, 66.67%
Cardiac Failure Congestive: 2 people, 16.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 8.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Etomidate and have Hyperthyroid?

- Check whether Hyperthyroid is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Etomidate:

Etomidate (2,496 reports)

Hyperthyroid treatments and more:

Hyperthyroid (26,827 reports)

Browse all side effects of Etomidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperthyroid:

Hyperthyroid (1,143 drugs)

Browse all the conditions that are associated with Hyperthyroid:

Hyperthyroid (1,401 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etomidate (the active ingredients of Etomidate) and Etomidate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.